Hudson Institute of Medical Research is a co-leader of the Victorian Paediatric Cancer Consortium (VPCC), alongside The Royal Children’s Hospital (RCH), Monash Children’s Hospital (MCH), Murdoch Children’s Research Institute (MCRI), Monash University, University of Melbourne, Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute of Medical Research (WEHI) and the Children’s Cancer Foundation.

VPCC brings together leading children’s hospitals, medical research institutes and universities, each with unique capabilities in paediatric cancer research and clinical care. VPCC enables a state-wide, multidisciplinary, and collaborative approach to combatting childhood cancers, with the goal of improving outcomes for children and adolescents with cancer through world-class medical research and innovation. Learn more about VPCC.

Hudson Institute Programs

Next Generation Precision Medicine Program
Risk Stratification – Sarcomas Program

Victorian Paediatric Cancer Consortium co-leads

Professor Ron Firestein, Hudson Institute
Professor David Eisenstat, The Royal Children’s Hospital and Murdoch Children’s Research Institute
Program Manager, Eliza Metcalfe
Director of Operations, Naama Neeman

VPCC was made possible thanks to the tireless efforts of the Children’s Cancer Foundation and funding from the Australian Government’s Medical Research Future Fund (MRFF).

Partners

Contact

Naama Neeman
VPCC, Director of Operations
e: naama.neeman@hudson.org.au